MicroPort CardioFlow Medtech (STU:72X) Total Liabilities : €38.39 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Total Liabilities?

MicroPort CardioFlow Medtech's Total Liabilities for the quarter that ended in Jun. 2024 was €38.39 Mil.

MicroPort CardioFlow Medtech's quarterly Total Liabilities declined from Jun. 2023 (€31.14 Mil) to Dec. 2023 (€31.11 Mil) but then increased from Dec. 2023 (€31.11 Mil) to Jun. 2024 (€38.39 Mil).

MicroPort CardioFlow Medtech's annual Total Liabilities declined from Dec. 2021 (€36.89 Mil) to Dec. 2022 (€33.52 Mil) and declined from Dec. 2022 (€33.52 Mil) to Dec. 2023 (€31.11 Mil).

MicroPort CardioFlow Medtech Total Liabilities Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Total Liabilities Chart

MicroPort CardioFlow Medtech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

53.13

183.19

36.89

33.52

31.11

MicroPort CardioFlow Medtech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial						32.14	33.52	31.14	31.11	38.39

MicroPort CardioFlow Medtech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MicroPort CardioFlow Medtech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.861	+	(5.383	+	0.867
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	31.11

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	330.972	-	299.861
	=	31.11

MicroPort CardioFlow Medtech's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	31.894	+	(5.642	+	0.855
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	38.39

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	319.807	-	281.416
	=	38.39

MicroPort CardioFlow Medtech Total Liabilities Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (STU:72X) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

02160:Hong Kong

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

MicroPort CardioFlow Medtech Headlines

No Headlines